West Pharmaceutical raises dividend to USD 0.26 per share for West Pharmaceutical stock
Published on 10/25/2026 at 14:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSIncome and dates guide the setup
- West Pharmaceutical declared a USD 0.26 dividend on October 19, 2026, up 18 percent from the prior quarter.
- Full-year adjusted earnings per share guidance stands at USD 8.85-9.05 for fiscal year 2026.
- West Pharmaceutical stock was last at EUR 351.10 on October 23, 2026 at Tradegate.
West Pharmaceutical Services, Inc. (ISIN US9553061055) declared a fourth-quarter dividend of USD 0.26 per share on October 19, 2026, an 18 percent increase from USD 0.22. The PR Newswire release also set November 11, 2026, as the record date and November 18, 2026, as the payment date.
What does 18 percent mean?
The dividend increase extends West Pharmaceutical's annual streak to 34 consecutive increases. At the declared rate, four quarterly payments would total USD 1.04 per share, although the annualized amount is not a company forecast.
The income announcement arrives before the company's next scheduled report. West Pharmaceutical said on October 8, 2026, that third-quarter results would be released before the market opens on October 29, 2026.
Three recent company markers
On October 13, 2026, TD Cowen raised its West Pharmaceutical price target from USD 410 to USD 420, as Markets Insider reported. On October 15, 2026, Zacks cited fiscal year 2026 adjusted earnings per share guidance of USD 8.85-9.05 and organic revenue growth of 10-11%. On October 19, 2026, the board declared the USD 0.26 dividend.
Dates investors can measure
The next scheduled company date is October 29, 2026, for third-quarter results. The dividend payment follows on November 18, 2026, for shareholders of record on November 11, 2026.
Stock valuation and the next report
West Pharmaceutical had a market capitalization of USD 27.6 billion as of October 23, 2026. Its 52-week range was USD 223.83 to USD 397.16, leaving the October 23 close of USD 392.15 below the upper end of that range. The company operates in healthcare medical instruments and supplies and is included in the S&P 500.
The last available euro price came from Tradegate and stood at EUR 351.10 on October 23, 2026. The upcoming results will test whether the guidance range and the higher dividend can remain supported by the operating figures.
The further course of trading is shown by the continuously updated real-time quote of West Pharmaceutical stock.
West Pharmaceutical stock facts
- Company: West Pharmaceutical Services, Inc.
- ISIN: US9553061055
- Ticker: WST
- Primary exchange: NYSE
- Market capitalization: USD 27.6 billion (as of October 23, 2026)
- 52-week range: USD 223.83-397.16 (as of October 23, 2026)
- Sector / Industry: Healthcare / Medical Instruments and Supplies
- Index membership: S&P 500
Market context: Market report S&P 500.
